Pharma

Your Article Summary

See Latest Articles

Angiotech pharmaceuticals announces launch of quill srs product codes for laparoscopic gynecology procedures
Angiotech Pharmaceuticals, 08/05/09

Angiotech Pharmaceuticals, Inc. announced the launch of a series of new, proprietary Quill SRS product codes specifically designed for laparoscopic, or minimally invasive, gynecology procedures, including hysterectomies and myomectomies. In 2008, there were approximately 750,000 hysterectomies performed in the United States of which approximately 130,000 were performed laparoscopically. In addition, there were approximately 72,000 myomectomies performed in the United States to remove uterine fibroid tumors. Management estimates 6–8% annual growth in laparoscopically assisted hysterectomies through 2014.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09

FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09

Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin
Roche, 12/14/09

 See all of Medical Devices/Products